Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06696183
What this trial is testing

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment

Who this might be right for
AML - Acute Myeloid Leukemia
Technische Universität Dresden 60
Testing effectiveness (Phase 2)Study completedNCT00047294
What this trial is testing

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Not applicableUnknownNCT06474988
What this trial is testing

Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

Who this might be right for
Breast CancerEstrogen Receptor Positive Tumor
European Institute of Oncology 150
Not applicableStudy completedNCT01898403
What this trial is testing

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Who this might be right for
Recurrent Melanoma
Stanford University 50
Large-scale testing (Phase 3)UnknownNCT00002869
What this trial is testing

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Medical Research Council 800
Not applicableStudy completedNCT01392222
What this trial is testing

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

Who this might be right for
Thyroid CancerPapillary Microcarcinoma
Memorial Sloan Kettering Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT03837873
What this trial is testing

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 118
Not applicableNot Yet RecruitingNCT07532473
What this trial is testing

REal World MAIA UK OutcomEs

Who this might be right for
Myeloma
The Royal Wolverhampton Hospitals NHS Trust 300
Testing effectiveness (Phase 2)Looking for participantsNCT07025369
What this trial is testing

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more
Mayo Clinic 30
Large-scale testing (Phase 3)Looking for participantsNCT06419946
What this trial is testing

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Vastra Gotaland Region 200
Testing effectiveness (Phase 2)Study completedNCT01830361
What this trial is testing

Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 18
Not applicableEnded earlyNCT00003654
What this trial is testing

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 200
Large-scale testing (Phase 3)Study completedNCT00408005
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Who this might be right for
T Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
National Cancer Institute (NCI) 1,895
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00646659
What this trial is testing

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Large-scale testing (Phase 3)Study completedNCT00302003
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Who this might be right for
Childhood Favorable Prognosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin Lymphoma+3 more
Children's Oncology Group 287
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07126561
What this trial is testing

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Who this might be right for
HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2
University of Chicago 43
Testing effectiveness (Phase 2)Study completedNCT00400816
What this trial is testing

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Who this might be right for
Central Nervous System TumorsBrain Tumor
The Cleveland Clinic 29
Not applicableLooking for participantsNCT06607783
What this trial is testing

PRostate Cancer Enhanced Diagnosis by Calibration Technology

Who this might be right for
Prostate Cancers
Gold Standard Phantoms 66
Large-scale testing (Phase 3)Ended earlyNCT00003880
What this trial is testing

Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Merck Sharp & Dohme LLC 132
Next Page